<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Alport Syndrome Management Algorithm</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.6;
            color: #333;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            background-attachment: fixed;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 20px;
            display: flex;
            gap: 25px;
        }

        .main-content {
            flex: 1;
            background: rgba(255, 255, 255, 0.95);
            border-radius: 20px;
            padding: 30px;
            box-shadow: 0 20px 60px rgba(0, 0, 0, 0.3);
            backdrop-filter: blur(10px);
        }

        .header {
            text-align: center;
            margin-bottom: 40px;
            padding-bottom: 20px;
            border-bottom: 3px solid #667eea;
        }

        .header h1 {
            font-size: 2.5em;
            color: #2c3e50;
            margin-bottom: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            gap: 15px;
        }

        .header p {
            font-size: 1.1em;
            color: #7f8c8d;
            margin-bottom: 15px;
        }

        .guideline-info {
            background: linear-gradient(135deg, #667eea, #764ba2);
            color: white;
            padding: 10px 20px;
            border-radius: 25px;
            font-size: 0.9em;
            display: inline-block;
        }

        .card {
            margin-bottom: 25px;
            border-radius: 15px;
            overflow: hidden;
            transition: all 0.3s ease;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1);
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.2);
        }

        .card-header {
            padding: 20px;
            color: white;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: space-between;
            transition: all 0.3s ease;
        }

        .card-header:hover {
            filter: brightness(1.1);
        }

        .card-header.assessment {
            background: linear-gradient(135deg, #3498db, #2980b9);
        }

        .card-header.diagnosis {
            background: linear-gradient(135deg, #9b59b6, #8e44ad);
        }

        .card-header.treatment {
            background: linear-gradient(135deg, #2ecc71, #27ae60);
        }

        .card-header.followup {
            background: linear-gradient(135deg, #e67e22, #d35400);
        }

        .card-title {
            display: flex;
            align-items: center;
            gap: 15px;
            font-size: 1.4em;
            font-weight: 600;
        }

        .card-icon {
            width: 40px;
            height: 40px;
            background: rgba(255, 255, 255, 0.2);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2em;
        }

        .expand-icon {
            transition: transform 0.3s ease;
            font-size: 1.5em;
        }

        .card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
            background: white;
        }

        .card.expanded .card-content {
            max-height: 2000px;
        }

        .card-body {
            padding: 25px;
        }

        .section {
            margin-bottom: 25px;
            padding-bottom: 20px;
            border-bottom: 1px solid #ecf0f1;
        }

        .section:last-child {
            border-bottom: none;
        }

        .section-title {
            font-size: 1.2em;
            font-weight: 600;
            color: #2c3e50;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .subsection {
            margin-bottom: 15px;
        }

        .subsection h4 {
            color: #34495e;
            margin-bottom: 10px;
            font-size: 1.05em;
        }

        .list {
            list-style: none;
            padding-left: 0;
        }

        .list li {
            padding: 8px 0;
            position: relative;
            padding-left: 25px;
        }

        .list li:before {
            content: "‚Ä¢";
            position: absolute;
            left: 0;
            color: #667eea;
            font-weight: bold;
            font-size: 1.2em;
        }

        .badge {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.8em;
            font-weight: 600;
            text-transform: uppercase;
            margin-left: 10px;
            box-shadow: 0 2px 5px rgba(0, 0, 0, 0.1);
        }

        .badge-red {
            background: linear-gradient(135deg, #e74c3c, #c0392b);
            color: white;
        }

        .badge-amber {
            background: linear-gradient(135deg, #f39c12, #e67e22);
            color: white;
        }

        .badge-green {
            background: linear-gradient(135deg, #2ecc71, #27ae60);
            color: white;
        }

        .alert {
            padding: 15px;
            border-radius: 10px;
            margin: 15px 0;
            border-left: 5px solid;
        }

        .alert-info {
            background: #d6eaf8;
            border-color: #3498db;
            color: #2c3e50;
        }

        .alert-warning {
            background: #fef9e7;
            border-color: #f1c40f;
            color: #7d6608;
        }

        .alert-danger {
            background: #fadbd8;
            border-color: #e74c3c;
            color: #78281f;
        }

        .alert-success {
            background: #d5f4e6;
            border-color: #27ae60;
            color: #196f3d;
        }

        .grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }

        .grid-item {
            background: #f8f9fa;
            padding: 15px;
            border-radius: 10px;
            border: 1px solid #e9ecef;
        }

        .drug-card {
            background: linear-gradient(135deg, #e8f8f5, #d1f2eb);
            border: 1px solid #a3e4d7;
            border-radius: 10px;
            padding: 15px;
            margin: 10px 0;
        }

        .drug-name {
            font-weight: 600;
            color: #27ae60;
            font-size: 1.1em;
        }

        .dosage {
            font-family: monospace;
            background: rgba(39, 174, 96, 0.1);
            padding: 5px 10px;
            border-radius: 5px;
            margin: 5px 0;
            display: inline-block;
        }

        .sidebar {
            width: 280px;
            position: sticky;
            top: 20px;
            height: fit-content;
        }

        .progress-card {
            background: rgba(255, 255, 255, 0.95);
            border-radius: 15px;
            padding: 20px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.2);
            backdrop-filter: blur(10px);
        }

        .progress-title {
            font-size: 1.2em;
            font-weight: 600;
            color: #2c3e50;
            margin-bottom: 20px;
            text-align: center;
        }

        .progress-item {
            padding: 12px;
            margin-bottom: 10px;
            border-radius: 10px;
            cursor: pointer;
            transition: all 0.3s ease;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .progress-item:hover {
            background: #f8f9fa;
        }

        .progress-item.active {
            background: linear-gradient(135deg, #667eea, #764ba2);
            color: white;
        }

        .progress-indicator {
            width: 22px;
            height: 22px;
            border-radius: 50%;
            border: 2px solid #bdc3c7;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 0.8em;
            font-weight: bold;
        }

        .progress-item.active .progress-indicator {
            border-color: white;
            background: white;
            color: #667eea;
        }

        .expand-all {
            text-align: center;
            margin-bottom: 20px;
        }

        .expand-all button {
            background: linear-gradient(135deg, #667eea, #764ba2);
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 25px;
            cursor: pointer;
            font-size: 1em;
            transition: all 0.3s ease;
        }

        .expand-all button:hover {
            transform: scale(1.05);
            box-shadow: 0 5px 15px rgba(102, 126, 234, 0.4);
        }

        .print-btn {
            background: linear-gradient(135deg, #3498db, #2980b9);
            color: white;
            border: none;
            padding: 8px 15px;
            border-radius: 20px;
            cursor: pointer;
            font-size: 0.9em;
            margin-left: 10px;
        }

        @media (max-width: 1024px) {
            .container {
                flex-direction: column;
            }
            
            .sidebar {
                width: 100%;
                position: static;
            }
            
            .progress-card {
                display: flex;
                overflow-x: auto;
                padding: 15px;
            }
            
            .progress-item {
                min-width: 150px;
                margin-bottom: 0;
                margin-right: 10px;
            }
        }

        @media (max-width: 768px) {
            .header h1 {
                font-size: 1.8em;
                flex-direction: column;
            }
            
            .main-content {
                padding: 20px;
            }
            
            .grid {
                grid-template-columns: 1fr;
            }
        }

        .print-only {
            display: none;
        }

        @media print {
            body {
                background: white;
            }
            
            .container {
                padding: 0;
            }
            
            .main-content {
                box-shadow: none;
                padding: 0;
            }
            
            .sidebar,
            .expand-all,
            .print-btn {
                display: none;
            }
            
            .card-content {
                max-height: none !important;
            }
            
            .card {
                page-break-inside: avoid;
                margin-bottom: 15px;
            }
            
            .print-only {
                display: block;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="main-content">
            <div class="header">
                <h1>
                    <span>üè•</span>
                    Alport Syndrome Management Algorithm
                </h1>
                <p>Evidence-based clinical decision support tool</p>
                <div class="guideline-info">
                    BMJ Best Practice Guidelines ‚Ä¢ Last updated: Feb 21, 2024
                </div>
                <button class="print-btn" onclick="window.print()">üñ®Ô∏è Print</button>
            </div>

            <div class="expand-all">
                <button onclick="toggleAllSections()">üîΩ Expand All Sections</button>
            </div>

            <!-- Assessment Card -->
            <div class="card" id="assessment-card" data-section="assessment">
                <div class="card-header assessment" onclick="toggleSection('assessment')">
                    <div class="card-title">
                        <div class="card-icon">üîç</div>
                        Assessment
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <div class="section-title">
                                Clinical Evaluation
                                <span class="badge badge-amber">Key Step</span>
                            </div>
                            <div class="alert alert-info">
                                <strong>Consider Alport syndrome in:</strong> Any child or adult with hematuria, proteinuria, deafness, hypertension, or renal failure
                            </div>
                            
                            <div class="subsection">
                                <h4>Key Diagnostic Factors</h4>
                                <ul class="list">
                                    <li><strong>Gross hematuria</strong> - Common in children, often precipitated by infection</li>
                                    <li><strong>Hearing impairment</strong> - Sensorineural, high-frequency loss</li>
                                    <li><strong>Family history</strong> of hematuria or renal failure</li>
                                    <li><strong>Hypertension</strong> - Sign of chronic kidney disease progression</li>
                                    <li><strong>Ocular changes</strong> - Lenticonus, maculopathy, early-onset cataracts</li>
                                    <li><strong>Fatigue & breathlessness</strong> - Vague symptoms of renal failure</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Risk Factors</h4>
                                <div class="grid">
                                    <div class="grid-item">
                                        <strong>Strong Risk Factors:</strong>
                                        <ul class="list">
                                            <li>Family history of Alport syndrome</li>
                                            <li>Male relative with renal failure + deafness</li>
                                            <li>Maternal history of microscopic hematuria</li>
                                        </ul>
                                    </div>
                                    <div class="grid-item">
                                        <strong>Other Risk Factors:</strong>
                                        <ul class="list">
                                            <li>Microscopic hematuria</li>
                                            <li>Family history of thin basement membrane nephropathy</li>
                                            <li>Parental consanguinity</li>
                                        </ul>
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Initial Investigations
                                <span class="badge badge-green">Essential</span>
                            </div>
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>Basic Tests</h4>
                                    <ul class="list">
                                        <li><strong>FBC:</strong> Check for anemia, elliptocytosis</li>
                                        <li><strong>Metabolic panel:</strong> Renal function, electrolytes</li>
                                        <li><strong>Fasting lipid panel:</strong> Dyslipidemia screening</li>
                                        <li><strong>Urinalysis:</strong> Hematuria, proteinuria quantification</li>
                                        <li><strong>Serum intact PTH:</strong> Bone mineral disorder screening</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Specialized Tests</h4>
                                    <ul class="list">
                                        <li><strong>Audiometry:</strong> High-tone sensorineural hearing loss</li>
                                        <li><strong>Ophthalmoscopy:</strong> Lenticonus, retinal abnormalities</li>
                                        <li><strong>Renal ultrasound:</strong> Exclude structural abnormalities</li>
                                        <li><strong>ECG/Echo:</strong> Cardiovascular assessment</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                When to Suspect
                                <span class="badge badge-red">High Priority</span>
                            </div>
                            <div class="alert alert-danger">
                                <strong>Strong suspicion if:</strong> Hematuria + proteinuria + progressive sensorineural hearing loss + characteristic ocular changes
                            </div>
                            <ul class="list">
                                <li>Males with XLAS: 80% present with microscopic/macroscopic hematuria</li>
                                <li>Females with XLAS: >95% have microscopic hematuria, 75% develop proteinuria</li>
                                <li>Autosomal forms: Equal severity in males and females</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="card" id="diagnosis-card" data-section="diagnosis">
                <div class="card-header diagnosis" onclick="toggleSection('diagnosis')">
                    <div class="card-title">
                        <div class="card-icon">üî¨</div>
                        Diagnosis
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <div class="section-title">
                                Diagnostic Approach
                                <span class="badge badge-amber">Multi-modal</span>
                            </div>
                            <div class="alert alert-info">
                                <strong>Recommended:</strong> Full clinical and family evaluation + molecular or pathological examination
                            </div>
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>Step 1: Clinical Evaluation</h4>
                                    <ul class="list">
                                        <li>Detailed family history</li>
                                        <li>Physical examination</li>
                                        <li>Audiometry and ophthalmoscopy</li>
                                        <li>Screen first-degree relatives</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Step 2: Confirmatory Testing</h4>
                                    <ul class="list">
                                        <li>Genetic testing (preferred)</li>
                                        <li>Renal biopsy (if needed)</li>
                                        <li>Skin biopsy (for XLAS)</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Diagnostic Criteria
                                <span class="badge badge-green">Clinical</span>
                            </div>
                            <div class="alert alert-success">
                                <strong>Classic Alport Syndrome requires:</strong> 2 or more of the following criteria
                            </div>
                            <ul class="list">
                                <li>Hematuria with/without progression to CKD + family history</li>
                                <li>Progressive sensorineural hearing loss</li>
                                <li>Characteristic ocular changes (lenticonus/maculopathy)</li>
                                <li>Typical ultrastructural changes in GBM</li>
                                <li>Diffuse leiomyomatosis</li>
                                <li>Abnormal type IV collagen distribution in skin/kidney biopsy</li>
                            </ul>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Confirmatory Testing
                                <span class="badge badge-amber">Essential</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>Genetic Testing <span class="badge badge-green">First-line</span></h4>
                                <ul class="list">
                                    <li><strong>Next-generation sequencing:</strong> COL4A3, COL4A4, COL4A5 genes</li>
                                    <li><strong>Benefits:</strong> Confirms diagnosis, identifies inheritance pattern, predicts phenotype</li>
                                    <li><strong>Indication:</strong> ‚â•2 diagnostic criteria or strong clinical suspicion</li>
                                    <li><strong>Family screening:</strong> Cascade testing for at-risk relatives</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Renal Biopsy <span class="badge badge-amber">Selective</span></h4>
                                <ul class="list">
                                    <li><strong>EM findings:</strong> Thinning, thickening, splitting, lamellation of GBM</li>
                                    <li><strong>Immunohistochemistry:</strong> Loss of type IV collagen chains</li>
                                    <li><strong>Indication:</strong> When genetic testing unavailable or inconclusive</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Skin Biopsy <span class="badge badge-amber">XLAS only</span></h4>
                                <ul class="list">
                                    <li><strong>Males:</strong> Absence of Œ±5(IV) staining in 80%</li>
                                    <li><strong>Females:</strong> Absent or discontinuous staining in 60%</li>
                                    <li><strong>Benefit:</strong> Less invasive, faster than genetic testing</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Differential Diagnoses
                                <span class="badge badge-amber">Consider</span>
                            </div>
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>Thin Basement Membrane Nephropathy</h4>
                                    <ul class="list">
                                        <li>Persistent microscopic hematuria only</li>
                                        <li>Family history of hematuria (no renal failure)</li>
                                        <li>Normal immunohistochemistry</li>
                                        <li>May share COL4A3/A4 mutations</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Other Differentials</h4>
                                    <ul class="list">
                                        <li><strong>IgA nephropathy:</strong> Usually no family history</li>
                                        <li><strong>FSGS:</strong> Often no hematuria</li>
                                        <li><strong>Branchio-oto-renal syndrome:</strong> Structural ear defects</li>
                                        <li><strong>MYH9 disorders:</strong> Macrothrombocytopenia</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Family Screening
                                <span class="badge badge-red">Critical</span>
                            </div>
                            <div class="alert alert-warning">
                                <strong>Early detection</strong> of hypertension/proteinuria allows intervention to slow disease progression
                            </div>
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>XLAS Families</h4>
                                    <ul class="list">
                                        <li>All daughters of affected males: 100% risk</li>
                                        <li>Sons of carrier females: 50% risk</li>
                                        <li>Male siblings: 50% risk, screen early</li>
                                        <li>All at-risk relatives: annual urinalysis + BP</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>ARAS Families</h4>
                                    <ul class="list">
                                        <li>Siblings: 25% risk of ARAS</li>
                                        <li>Parents: likely carriers with hematuria</li>
                                        <li>Offspring: obligate carriers</li>
                                        <li>Genetic counseling essential</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="card" id="treatment-card" data-section="treatment">
                <div class="card-header treatment" onclick="toggleSection('treatment')">
                    <div class="card-title">
                        <div class="card-icon">üíä</div>
                        Treatment
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <div class="section-title">
                                Management Approach
                                <span class="badge badge-green">Lifelong Care</span>
                            </div>
                            <div class="alert alert-info">
                                <strong>Core principle:</strong> Lifelong nephrology management with ACE inhibition to slow disease progression
                            </div>
                            <ul class="list">
                                <li>Manage hypertension, proteinuria, dyslipidemia</li>
                                <li>Target BP: <130/80 mmHg</li>
                                <li>Monitor for extra-renal complications</li>
                                <li>Genetic counseling and family screening</li>
                                <li>Prepare for renal replacement therapy</li>
                            </ul>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Pharmacotherapy
                                <span class="badge badge-red">Critical</span>
                            </div>
                            
                            <div class="alert alert-success">
                                <strong>Early ACE inhibition delays ESRD and improves survival</strong>
                            </div>

                            <div class="subsection">
                                <h4>Initiation Timing <span class="badge badge-amber">Genotype-specific</span></h4>
                                <div class="grid">
                                    <div class="grid-item">
                                        <h5>Start at diagnosis (age >12-24 months):</h5>
                                        <ul class="list">
                                            <li>All males with XLAS</li>
                                            <li>All patients with ARAS</li>
                                            <li>Before proteinuria appears</li>
                                        </ul>
                                    </div>
                                    <div class="grid-item">
                                        <h5>Start at microalbuminuria:</h5>
                                        <ul class="list">
                                            <li>Females with XLAS</li>
                                            <li>All patients with ADAS</li>
                                        </ul>
                                    </div>
                                </div>
                            </div>

                            <div class="subsection">
                                <h4>Recommended Agents</h4>
                                <div class="drug-card">
                                    <div class="drug-name">ACE Inhibitors (First-line)</div>
                                    <ul class="list">
                                        <li>Enalapril: <span class="dosage">5-20 mg orally daily</span></li>
                                        <li>Lisinopril: <span class="dosage">10-40 mg orally daily</span></li>
                                        <li>Fosinopril: <span class="dosage">20 mg orally daily</span></li>
                                        <li>Ramipril (children): <span class="dosage">Consult specialist</span></li>
                                    </ul>
                                </div>

                                <div class="drug-card">
                                    <div class="drug-name">Angiotensin-II Receptor Antagonists (Alternative)</div>
                                    <ul class="list">
                                        <li>Losartan: <span class="dosage">50-100 mg orally daily</span></li>
                                        <li>Irbesartan: <span class="dosage">150-300 mg orally daily</span></li>
                                    </ul>
                                </div>

                                <div class="drug-card">
                                    <div class="drug-name">Aldosterone Antagonists (Adjunct)</div>
                                    <ul class="list">
                                        <li>Spironolactone: <span class="dosage">Consult specialist</span></li>
                                        <li>May be combined with ACEi/ARB</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="alert alert-warning">
                                <strong>Monitoring required:</strong> Orthostatic hypotension, hyperkalemia, renal function
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Renal Replacement Therapy
                                <span class="badge badge-red">Advanced CKD</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>When to Consider <span class="badge badge-amber">GFR <20 mL/min</span></h4>
                                <ul class="list">
                                    <li>Education about dialysis options (hemodialysis, peritoneal dialysis)</li>
                                    <li>Refer for transplant evaluation</li>
                                    <li>Consider living donor assessment</li>
                                    <li>Address patient preferences and support systems</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Kidney Transplantation <span class="badge badge-green">Definitive Treatment</span></h4>
                                <div class="alert alert-danger">
                                    <strong>Post-transplant anti-GBM disease:</strong> 1-5% risk, usually within 1 year
                                </div>
                                <ul class="list">
                                    <li>Screen for anti-GBM antibodies regularly</li>
                                    <li>Higher risk with loss-of-function mutations</li>
                                    <li>Graft loss risk is high if anti-GBM develops</li>
                                    <li>Recurrence in second grafts is common</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Living Donor Selection <span class="badge badge-amber">Careful Screening</span></h4>
                                <ul class="list">
                                    <li>Screen relatives for hematuria first</li>
                                    <li>Genetic testing to guide selection</li>
                                    <li>Non-carriers may be considered</li>
                                    <li>XLAS carrier females: donation carries risk, long-term prognosis unknown</li>
                                    <li>ARAS carriers typically not considered</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Extra-renal Management
                                <span class="badge badge-green">Multidisciplinary</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>Sensorineural Hearing Loss</h4>
                                <ul class="list">
                                    <li>Audiology monitoring from age 5 years (males XLAS, all ARAS)</li>
                                    <li>Hearing aids for management</li>
                                    <li>Education on noise-induced injury prevention</li>
                                    <li><strong>Note:</strong> Does not improve with transplant</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Visual Complications</h4>
                                <ul class="list">
                                    <li>Annual ophthalmology surveillance for children with lenticonus</li>
                                    <li>Cataract surgery when indicated</li>
                                    <li>Adult complications rare</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Diffuse Leiomyomatosis <span class="badge badge-amber">Rare</span></h4>
                                <ul class="list">
                                    <li>Surgery for symptomatic leiomyomas</li>
                                    <li>May involve esophagus, respiratory tract, genital tract</li>
                                    <li>Associated with COL4A5-A6 deletions</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Emerging Therapies
                                <span class="badge badge-amber">Investigational</span>
                            </div>
                            <ul class="list">
                                <li><strong>Dual/triple RAAS blockade:</strong> May reduce proteinuria further</li>
                                <li><strong>Ciclosporin:</strong> Nephrotoxicity likely outweighs benefits</li>
                                <li><strong>Bardoxolone methyl:</strong> FDA/EMA not approved (insufficient benefit-risk data)</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="card" id="followup-card" data-section="followup">
                <div class="card-header followup" onclick="toggleSection('followup')">
                    <div class="card-title">
                        <div class="card-icon">üìä</div>
                        Follow-up
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <div class="section-title">
                                Monitoring Protocol
                                <span class="badge badge-green">Routine</span>
                            </div>
                            <div class="alert alert-info">
                                <strong>Frequency:</strong> At least annually, more frequently as renal function declines
                            </div>
                            
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>Renal Monitoring</h4>
                                    <ul class="list">
                                        <li>Serum creatinine/eGFR</li>
                                        <li>Urinalysis (hematuria, proteinuria)</li>
                                        <li>Blood pressure</li>
                                        <li>Fasting lipid panel</li>
                                        <li>Calcium, phosphate, PTH</li>
                                        <li>FBC (anemia screening)</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Extra-renal Monitoring</h4>
                                    <ul class="list">
                                        <li>Audiometry (annually from age 5)</li>
                                        <li>Ophthalmology (children with lenticonus)</li>
                                        <li>Growth monitoring (children)</li>
                                        <li>Depression screening</li>
                                        <li>Cardiovascular assessment</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Complications to Monitor
                                <span class="badge badge-amber">Vigilance</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>Chronic Kidney Disease <span class="badge badge-red">High Risk</span></h4>
                                <ul class="list">
                                    <li>Anemia, hyperparathyroidism, metabolic acidosis</li>
                                    <li>Cardiovascular disease (most common cause of mortality)</li>
                                    <li>Protein malnutrition, hyperkalemia</li>
                                    <li>Early nephrology referral for RRT preparation</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Pregnancy Complications <span class="badge badge-amber">Moderate Risk</span></h4>
                                <div class="alert alert-warning">
                                    <strong>Risk factors:</strong> Pre-pregnancy serum creatinine ‚â•106 Œºmol/L (‚â•1.2 mg/dL)
                                </div>
                                <ul class="list">
                                    <li>New or worsening hypertension</li>
                                    <li>Pre-eclampsia</li>
                                    <li>Fetal and maternal complications</li>
                                    <li>Close obstetric-nephrology collaboration</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Other Complications</h4>
                                <ul class="list">
                                    <li><strong>Depression:</strong> Frequent, screen regularly</li>
                                    <li><strong>Hearing loss progression:</strong> Irreversible, monitor annually</li>
                                    <li><strong>Visual complications:</strong> Rare in adults</li>
                                    <li><strong>Post-transplant anti-GBM:</strong> 1-5% risk</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Prognosis
                                <span class="badge badge-amber">Genotype-dependent</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>X-linked Alport Syndrome (Males)</h4>
                                <ul class="list">
                                    <li><strong>100% develop CKD</strong> - rate varies by mutation</li>
                                    <li>Loss-of-function mutations: >90% develop CKD by age 30</li>
                                    <li>Early ACE inhibition delays ESRD and improves survival</li>
                                    <li>Median age at ESRD: ~25 years (untreated)</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>X-linked Alport Syndrome (Females)</h4>
                                <ul class="list">
                                    <li>12% develop CKD before age 40</li>
                                    <li>15-30% risk of renal failure by age 60</li>
                                    <li>30% have some hearing impairment</li>
                                    <li>15% have ocular signs</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Autosomal Forms</h4>
                                <ul class="list">
                                    <li><strong>ARAS:</strong> Median age at ESRD 22.5 years (range 10-38)</li>
                                    <li><strong>ADAS:</strong> Mild phenotype, slow progression</li>
                                    <li><strong>Digenic:</strong> Phenotype between ARAS and ADAS</li>
                                    <li>Loss-of-function allele predicts earlier ESRD</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Patient Education & Counseling
                                <span class="badge badge-green">Essential</span>
                            </div>
                            
                            <div class="subsection">
                                <h4>Key Topics to Discuss</h4>
                                <ul class="list">
                                    <li>Disease course and variable manifestations</li>
                                    <li>Importance of BP and proteinuria control</li>
                                    <li>Renal replacement therapy options</li>
                                    <li>Hearing loss management</li>
                                    <li>Risk reduction strategies</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Genetic Counseling</h4>
                                <ul class="list">
                                    <li>Reproductive options and prenatal testing</li>
                                    <li>Family screening recommendations</li>
                                    <li>Donor evaluation for kidney transplantation</li>
                                    <li>Support groups and resources</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Lifestyle Recommendations</h4>
                                <ul class="list">
                                    <li><strong>Diet:</strong> Low-salt, high-fiber, protein 0.8g/kg/day</li>
                                    <li><strong>Smoking:</strong> Strict avoidance</li>
                                    <li><strong>Noise exposure:</strong> Minimize to protect hearing</li>
                                    <li><strong>BP monitoring:</strong> Home monitoring encouraged</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <div class="section-title">
                                Key Guidelines
                                <span class="badge badge-green">References</span>
                            </div>
                            <div class="grid">
                                <div class="grid-item">
                                    <h4>Diagnostic Guidelines</h4>
                                    <ul class="list">
                                        <li>Scottish Paediatric Renal Urology Network (2019)</li>
                                        <li>Alport Syndrome Classification Working Group (2018)</li>
                                        <li>KDIGO CKD Guidelines (2012)</li>
                                        <li>ASN Genetic Testing Guidelines (2022)</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Treatment Guidelines</h4>
                                    <ul class="list">
                                        <li>Alport Syndrome Research Collaborative (2021)</li>
                                        <li>ASN Management Guidelines (2013, 2022)</li>
                                        <li>KDIGO CKD Evaluation & Management (2012)</li>
                                        <li>Consensus Molecular Diagnostics (2021)</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="print-only" style="margin-top: 30px; padding: 20px; background: #f8f9fa; border-radius: 10px;">
                <p><strong>Disclaimer:</strong> This algorithm is for educational purposes only. Clinical decisions should be based on individual patient assessment and current guidelines. Refer to BMJ Best Practice for full details and updates.</p>
            </div>
        </div>

        <!-- Progress Sidebar -->
        <div class="sidebar">
            <div class="progress-card">
                <div class="progress-title">üìç Progress</div>
                <div class="progress-item active" onclick="scrollToSection('assessment')" data-section="assessment">
                    <div class="progress-indicator">1</div>
                    <span>Assessment</span>
                </div>
                <div class="progress-item" onclick="scrollToSection('diagnosis')" data-section="diagnosis">
                    <div class="progress-indicator">2</div>
                    <span>Diagnosis</span>
                </div>
                <div class="progress-item" onclick="scrollToSection('treatment')" data-section="treatment">
                    <div class="progress-indicator">3</div>
                    <span>Treatment</span>
                </div>
                <div class="progress-item" onclick="scrollToSection('followup')" data-section="followup">
                    <div class="progress-indicator">4</div>
                    <span>Follow-up</span>
                </div>
                <div style="margin-top: 20px; padding-top: 20px; border-top: 2px solid #ecf0f1;">
                    <button onclick="window.print()" style="width: 100%; padding: 10px; background: linear-gradient(135deg, #3498db, #2980b9); color: white; border: none; border-radius: 25px; cursor: pointer;">
                        üñ®Ô∏è Generate Report
                    </button>
                </div>
            </div>
        </div>
    </div>

    <script>
        // State management
        const expandedSections = new Set();
        let allExpanded = false;

        // Initialize from localStorage
        function initializeState() {
            const saved = localStorage.getItem('alportSections');
            if (saved) {
                const sections = JSON.parse(saved);
                sections.forEach(section => {
                    const card = document.getElementById(`${section}-card`);
                    if (card) {
                        expandedSections.add(section);
                        card.classList.add('expanded');
                    }
                });
            } else {
                // Default: expand assessment only
                expandedSections.add('assessment');
                document.getElementById('assessment-card').classList.add('expanded');
            }
            updateProgress();
        }

        // Save state to localStorage
        function saveState() {
            localStorage.setItem('alportSections', JSON.stringify([...expandedSections]));
        }

        // Toggle individual section
        function toggleSection(section) {
            const card = document.getElementById(`${section}-card`);
            const wasExpanded = card.classList.contains('expanded');
            
            if (wasExpanded) {
                card.classList.remove('expanded');
                expandedSections.delete(section);
            } else {
                card.classList.add('expanded');
                expandedSections.add(section);
            }
            
            saveState();
            updateProgress();
        }

        // Toggle all sections
        function toggleAllSections() {
            const cards = ['assessment', 'diagnosis', 'treatment', 'followup'];
            
            if (allExpanded) {
                // Collapse all
                cards.forEach(section => {
                    document.getElementById(`${section}-card`).classList.remove('expanded');
                });
                expandedSections.clear();
                allExpanded = false;
                event.target.textContent = 'üîΩ Expand All Sections';
            } else {
                // Expand all
                cards.forEach(section => {
                    document.getElementById(`${section}-card`).classList.add('expanded');
                    expandedSections.add(section);
                });
                allExpanded = true;
                event.target.textContent = 'üîº Collapse All Sections';
            }
            
            saveState();
            updateProgress();
        }

        // Update progress sidebar
        function updateProgress() {
            const progressItems = document.querySelectorAll('.progress-item');
            progressItems.forEach(item => {
                const section = item.dataset.section;
                if (expandedSections.has(section)) {
                    item.classList.add('active');
                } else {
                    item.classList.remove('active');
                }
            });
        }

        // Scroll to section
        function scrollToSection(section) {
            const card = document.getElementById(`${section}-card`);
            if (card) {
                card.scrollIntoView({ behavior: 'smooth', block: 'start' });
                
                // Auto-expand if collapsed
                if (!expandedSections.has(section)) {
                    toggleSection(section);
                }
            }
        }

        // Add smooth scroll behavior
        document.addEventListener('DOMContentLoaded', function() {
            initializeState();
            
            // Check if all sections are expanded
            if (expandedSections.size === 4) {
                allExpanded = true;
                document.querySelector('.expand-all button').textContent = 'üîº Collapse All Sections';
            }
        });

        // Add intersection observer for scroll spy
        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    const section = entry.target.dataset.section;
                    const progressItem = document.querySelector(`.progress-item[data-section="${section}"]`);
                    
                    // Remove active class from all progress items
                    document.querySelectorAll('.progress-item').forEach(item => {
                        item.classList.remove('active');
                    });
                    
                    // Add active class to current section
                    if (progressItem) {
                        progressItem.classList.add('active');
                    }
                }
            });
        }, { threshold: 0.3 });

        // Observe all cards
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.card').forEach(card => {
                observer.observe(card);
            });
        });

        // Print optimization
        window.addEventListener('beforeprint', () => {
            // Expand all sections for printing
            document.querySelectorAll('.card').forEach(card => {
                card.classList.add('expanded');
            });
        });

        window.addEventListener('afterprint', () => {
            // Restore previous state
            initializeState();
        });
    </script>
</body>
</html>